Total medical devices industry M&A deals in July 2020 worth $1.87bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 3.6% over the previous month and a drop of 35.3% when compared with the last 12-month average, which stood at $2.89bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $1.43bn. At the country level, the US topped the list in terms of deal value at $1.43bn.

In terms of volumes, Europe emerged as the top region for medical devices industry M&A deals globally, followed by North America and then Asia-Pacific.

The top country in terms of M&A deals activity in July 2020 was the US with 14 deals, followed by the UK with five and China with three.

In 2020, as of the end of July 2020, medical devices M&A deals worth $19.22bn were announced globally, marking a decrease of 31.8% year on year.

Medical devices industry M&A deals in July 2020: Top deals

The top five medical devices industry M&A deals accounted for 88.4% of the overall value during July 2020.

The combined value of the top five medical devices M&A deals stood at $1.66bn, against the overall value of $1.87bn recorded for the month.

The top five medical devices industry deals of July 2020 tracked by GlobalData were:

1) The merger of Healthcare Merger and SOC Telemed for $720m

2) The $525m asset transaction with DXC Technology by Dedalus

3) Medtronic‘s $187.06m acquisition of MEDICREA Group

4) The $140m asset transaction with Sarnova by R1 RCM

5) SK Group’s acquisition of Innometry for $83m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.